Reestablishing the expression of miRs using miRNA-mimics delivered via viral and non-viral (locked nucleic acids or liposomal nanoparticles) systems into the tumor tissue of NSCLC patients might provide an additional tool for suppressing tumor growth and improve the efficacy of EGFR-TKIS. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.